RJ Hamster
ExxonMobil scientists are pioneering new research & technologies to reduce emissions. Learn how we are responsibly meeting the world’s energy needs.
— Read on corporate.exxonmobil.com/
RJ Hamster
A can crusher quit for a depressing reason! This recycling pun crushes perfect wordplay pressure. Click for the cold hard truth!
— Read on humorhq.net/posts/can-crusher-career
RJ Hamster
Trump Bans AI Firm’s Model | Republican Nation
— Read on republicannation.com/trump-bans-ai-firms-model/
RJ Hamster
Home – Real Talk Digest
— Read on realtalkdigest.com/
RJ Hamster
Trump: No Ground War—But No Self-Imposed Limits | United Voice
— Read on www.unitedvoice.com/trump-no-ground-war-but-no-self-imposed-limits/
RJ Hamster
Start your day with the trends that move the markets. Fast, insightful, and straight to your inbox.
— Read on elitetrade.club/
RJ Hamster
Fox News Host Warns VP Vance | Headline Reporter
— Read on headlinereporter.com/2026/03/fox-news-host-warns-vp-vance/
RJ Hamster
End of Season Sale
— Read on piloti.com/collections/end-of-season-sale
RJ Hamster
3 tickers just showed unusual early patterns. See the Trading Ideas report now.(From Trading Ideas)
Written by Chris Markoch on March 8, 2026
Sector rotation is a common occurrence in which investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that means rotating away from mega-cap technology stocks and into value stocks, particularly those in defensive sectors like energy and consumer staples.
The keyword is overvalued. Big tech has been running hot for over two years. That’s due to the emergence of artificial intelligence (AI). Despite concerns of a dot-com bubble repeat, investors mostly ignored the lofty valuations of many of these stocks.
But investors who believed this time was different are discovering that valuation doesn’t matter until it does. As the economy begins to heat up, investors are looking for value in other areas. One of those areas is in blue-chip defensive names like the stocks listed here.
What if a tiny NASDAQ tech company was already working with some of the largest corporations on the planet… 🤯
Yet its market cap is still under $20 million as of the first week of March.Click the link below to see why.
Duke Energy (NYSE: DUK) is one of the most logical beneficiaries of sector rotation. Duke is a well-known utility provider primarily in the Southeast and Midwest United States. Utilities stocks are among the most defensive stocks. They are typically thought of as value and income stocks. And Duke Energy does offer an attractive, secure dividend that yields around 3.2%. The company has increased the payout of that dividend for 20 consecutive years.
However, the dynamic energy landscape in the United States is opening a window for future growth with DUK stock. The company has an “all of the above” approach to generating power. That includes nuclear, hydroelectric, and natural gas.
The latter is responsible for the stock’s strong bounce in 2026. However, it’s the company’s stable base of revenue from its residential utility business, coupled with projected future growth in areas like data centers, that is making DUK stock a sector rotation target.
DUK stock is up nearly 12% in 2026. That puts the stock within 5% of its consensus price target of $136.87, which would push the stock above its 52-week high. At around 20.5x earnings, the stock is trading at a slight premium to its historic average.
However, since the company reported earnings in February, analysts have been raising their price targets with expectations of strong year-over-year (YOY) revenue growth in the second half of the year. That could lead to a bullish re-rating.
Some analysts are forecasting biotechnology stocks to benefit from the current sector rotation. Gilead Sciences (NASDAQ: GILD)offers defense growth among healthcare stocks, which have largely underperformed the broader market.
Gilead is one of the leading providers of HIV therapies, with its leading drugs having patent protection into the 2030s. Investors are also energized about the company’s pipeline, which includes over 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma in 2026. The company may also get a label expansion for its breast cancer drug, Trodelvy.
GILD stock is up nearly 18% in 2026. That pushed the stock to a 52-week high. It’s down slightly from that level as of this writing. But that may be some profit-taking after an outsized run-up. That’s likely to make GILD stock a buy-the-dip opportunity.
Analysts have a consensus price target of $156.72 on GILD stock. That’s a gain of over 8%. However, since the company’s earnings report in February, many analysts have raised their price targets, with the highest estimates coming in at $170.
Gilead also pays a reliable dividend with a yield of 2.28%. The company has also raised its dividend for 10 consecutive years.
See Where Early Market Signals Are Forming
Alpha Wire Daily tracks developing activity across small caps—where subtle shifts begin to take shape. These are often the setups that appear before broader attention builds.Get Free Alerts — Stay Ahead of the Signals
The Hershey Company (NYSE: HSY) is one of the strongest beneficiaries of the rotation into consumer staples stocks in 2026. HSY stock is up nearly 25% in 2026 and has broken out of the bearish trend it was in since 2023.
At that time, the company began dealing with the impact of higher cocoa prices that extended through 2025. That’s still going to weigh on earnings in 2026. However, the market is forward-looking, and that’s part of the growth story. Analysts are forecasting strong growth in earnings and revenue in 2026.
HSY stock is trading above its consensus price target of $222.21. However, since the company’s earnings report in February, analysts have been raising their price targets. The most bullish call comes from Goldman Sachs, which has a $267 target.
In that earnings report, Hershey also increased its dividend by 5.9%. That made it 15 consecutive years of increases for a company that has a dividend yield of around 2.5% and an annual payout per share of $5.81.
Since the latest run-up, HSY stock is trading at over 50x earnings. That’s a likely reason for the heavy institutional selling in the last quarter, but it could present investors with a chance to get a second bite at this sweet stock.
Further Reading
Did you find this article useful?
Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO’s, CFO’s, COO’s and other insiders.
If you need assistance with your newsletter, feel free to email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl., Suite 620, Sioux Falls, South Dakota 57103-7078. USA..
Read More: I got my hands on a declassified government cable. It changes everything. (From The Oxford Club)
RJ Hamster